Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China flag China · Delayed Price · Currency is CNY
3.300
+0.120 (3.77%)
Apr 29, 2026, 3:04 PM CST

SHE:002390 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,1141,016805.98899.18624.65
Cash & Short-Term Investments
1,1141,016805.98899.18624.65
Cash Growth
9.69%26.00%-10.37%43.95%-64.84%
Accounts Receivable
2,4682,6913,0363,0913,082
Other Receivables
256320.24324.63448.8600.56
Receivables
2,7243,0123,3613,5403,682
Inventory
901.231,0601,0011,033935.71
Prepaid Expenses
-0.020.030.020.02
Other Current Assets
103.97164.39243.61334.34333.72
Total Current Assets
4,8435,2525,4125,8065,576
Property, Plant & Equipment
2,3392,4262,5182,6722,706
Long-Term Investments
402.52337.47340.47343.84347.41
Goodwill
593.64603.75603.75607.35607.35
Other Intangible Assets
176.61189.54180.18204.37217.65
Long-Term Deferred Tax Assets
110.2781.8774.1462.8155.61
Long-Term Deferred Charges
58.1169.381.8497.21118.36
Other Long-Term Assets
6768.5735--
Total Assets
8,5919,0289,2459,7949,629
Accounts Payable
822.55927.97903.15977.24993.43
Accrued Expenses
22.3937.1535.2732.9940.93
Short-Term Debt
269.61603.54809.861,3681,390
Current Portion of Long-Term Debt
106.12----
Current Portion of Leases
-34.42.51-
Current Income Taxes Payable
30.167.621.0917.2117.79
Current Unearned Revenue
25.7725.9427.9833.2455.44
Other Current Liabilities
187.37201.68256.82255.56256.6
Total Current Liabilities
1,4641,8072,0592,6872,755
Long-Term Debt
37160---
Long-Term Leases
18.032121.1222.0224.81
Long-Term Unearned Revenue
20.2219.5222.0418.8920.38
Long-Term Deferred Tax Liabilities
13.190.730.840.56-
Other Long-Term Liabilities
0.280.290.310.320.34
Total Liabilities
1,5532,0082,1032,7292,800
Common Stock
1,9441,9441,9441,9442,027
Additional Paid-In Capital
4,4034,4034,4034,4024,693
Retained Earnings
569.93563.43633.34462.74354.99
Treasury Stock
-199.93-199.93-127.49--455.38
Comprehensive Income & Other
72.93----
Total Common Equity
6,7906,7106,8526,8086,620
Minority Interest
247.95309.87289.69256.55208.74
Shareholders' Equity
7,0387,0207,1427,0656,829
Total Liabilities & Equity
8,5919,0289,2459,7949,629
Total Debt
430.76787.55835.381,3931,415
Net Cash (Debt)
683.13227.97-29.4-493.42-790.6
Net Cash Growth
199.66%----
Net Cash Per Share
0.360.11-0.02-0.26-0.43
Filing Date Shares Outstanding
1,8981,8961,9071,9441,944
Total Common Shares Outstanding
1,8981,8961,9071,9441,944
Working Capital
3,3793,4453,3533,1192,822
Book Value Per Share
3.583.543.593.503.41
Tangible Book Value
6,0205,9176,0685,9975,795
Tangible Book Value Per Share
3.173.123.183.082.98
Buildings
-2,5172,5162,5782,396
Machinery
-1,7161,7221,6971,641
Construction In Progress
-145.0258.0624.9892.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.